STOCK TITAN

[Form 4] SunLink Health Systems, Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Sheila G. Brockman, listed with an Atlanta address, filed a Form 4 regarding SunLink Health Systems, Inc. (SSY) with an earliest transaction date of 08/14/2025. The filing identifies her relationship to the issuer as an Officer and notes she is a former VP of SSY and CEO of a subsidiary. The form does not include any populated transaction tables or disclose the type, quantity, or price of securities traded; the signature block shows execution by M. Timothy Elder under power of attorney on 08/14/2025.

Sheila G. Brockman, registrata con un indirizzo a Atlanta, ha presentato un Modulo 4 riguardo a SunLink Health Systems, Inc. (SSY) con una data di operazione più temprata del 14/08/2025. L'atto identifica il suo rapporto con l'emittente come Dirigente e segnala che è stata vicepresidente di SSY e CEO di una sussidiaria. Il modulo non contiene alcuna tabella di operazioni compilata né rivela il tipo, la quantità o il prezzo delle obbligazioni/valori negoziati; il blocco della firma mostra l'esecuzione da parte di M. Timothy Elder tramite procura il 14/08/2025.

Sheila G. Brockman, registrada con una dirección en Atlanta, presentó un Formulario 4 respecto a SunLink Health Systems, Inc. (SSY) con una fecha de operación más temprana del 14/08/2025. La presentación identifica su relación con el emisor como Oficial y señala que es ex vicepresidenta de SSY y CEO de una subsidiaria. El formulario no incluye ninguna tabla de transacciones pobladas ni divulga el tipo, la cantidad o el precio de los valores negociados; el bloque de firma muestra la ejecución por M. Timothy Elder bajo poder notarial el 14/08/2025.

Sheila G. Brockman은 애틀랜타 주소로 등재되어 있으며 SunLink Health Systems, Inc. (SSY)에 관한 Form 4를 제출했고 최초 거래 날짜는 2025년 8월 14일입니다. 신고서는 발행자와의 관계를 임원으로 식별하고 SSY의 전 부사장이자 자회사의 CEO였다고 명시합니다. 양식에는 채워진 거래 표가 포함되어 있지 않으며 종류, 수량 또는 가격의 증권 거래를 공개하지 않습니다; 서명란은 M. Timothy Elder가 위임장에 따라 2025년 8월 14일에 실행한 것으로 표시합니다.

Sheila G. Brockman, répertoriée avec une adresse à Atlanta, a déposé un Form 4 concernant SunLink Health Systems, Inc. (SSY) avec une date de transaction la plus ancienne du 14/08/2025. Le dossier identifie sa relation avec l'émetteur comme Dirigeante et indique qu'elle est ancienne vice-présidente de SSY et PDG d'une filiale. Le formulaire n'inclut aucun tableau de transactions rempli ni ne divulgue le type, la quantité ou le prix des titres négociés; le bloc de signature montre une exécution par M. Timothy Elder sous procuration le 14/08/2025.

Sheila G. Brockman, mit einer Adresse in Atlanta aufgeführt, hat ein Formular 4 in Bezug auf SunLink Health Systems, Inc. (SSY) eingereicht, mit dem frühesten Transaktionsdatum 14.08.2025. Die Einreichung kennzeichnet ihre Beziehung zum Emittenten als Beauftragte/r und vermerkt, dass sie frühere VP von SSY und CEO einer Tochtergesellschaft war. Das Formular enthält keine ausgefüllten Transaktionstabellen und gibt weder den Typ, die Menge noch den Preis der gehandelten Wertpapiere an; der Unterschriftsblock zeigt die Ausführung durch M. Timothy Elder unter Vollmacht am 14.08.2025.

شَيلَة ج. بروكمان، المدرجة بعنوان في أتلانتا، قدمت النموذج 4 فيما يتعلق بـ SunLink Health Systems, Inc. (SSY) مع أقرب تاريخ للمعاملة في 14/08/2025. يحدد التسجيل علاقتها بالمصدر كـ موظف ويشير إلى أنها كانت نائب رئيس SSY والرئيس التنفيذي لأحدى الشركات التابعة. لا يتضمن النموذج أي جداول معاملات مملوءة أو يكشف عن النوع، الكمية أو السعر للأسهم المتداولة؛ كتلة التوقيع تُظهر التنفيذ بواسطة M. Timothy Elder بموجب توكيل في 14/08/2025.

Sheila G. Brockman,列有亚特兰大地址,提交了关于 SunLink Health Systems, Inc.(SSY)的 Form 4,最早交易日期为 2025/08/14。该申报将她与发行人的关系标注为 高级职员,并指出她曾任 SSY 的副总裁及一家子公司的首席执行官。表格未包含任何填充的交易表,也未披露所交易证券的 类型数量价格;签名栏显示由 M. Timothy Elder 在授权书下于 2025/08/14 执行。

Positive
  • None.
Negative
  • None.

Sheila G. Brockman, registrata con un indirizzo a Atlanta, ha presentato un Modulo 4 riguardo a SunLink Health Systems, Inc. (SSY) con una data di operazione più temprata del 14/08/2025. L'atto identifica il suo rapporto con l'emittente come Dirigente e segnala che è stata vicepresidente di SSY e CEO di una sussidiaria. Il modulo non contiene alcuna tabella di operazioni compilata né rivela il tipo, la quantità o il prezzo delle obbligazioni/valori negoziati; il blocco della firma mostra l'esecuzione da parte di M. Timothy Elder tramite procura il 14/08/2025.

Sheila G. Brockman, registrada con una dirección en Atlanta, presentó un Formulario 4 respecto a SunLink Health Systems, Inc. (SSY) con una fecha de operación más temprana del 14/08/2025. La presentación identifica su relación con el emisor como Oficial y señala que es ex vicepresidenta de SSY y CEO de una subsidiaria. El formulario no incluye ninguna tabla de transacciones pobladas ni divulga el tipo, la cantidad o el precio de los valores negociados; el bloque de firma muestra la ejecución por M. Timothy Elder bajo poder notarial el 14/08/2025.

Sheila G. Brockman은 애틀랜타 주소로 등재되어 있으며 SunLink Health Systems, Inc. (SSY)에 관한 Form 4를 제출했고 최초 거래 날짜는 2025년 8월 14일입니다. 신고서는 발행자와의 관계를 임원으로 식별하고 SSY의 전 부사장이자 자회사의 CEO였다고 명시합니다. 양식에는 채워진 거래 표가 포함되어 있지 않으며 종류, 수량 또는 가격의 증권 거래를 공개하지 않습니다; 서명란은 M. Timothy Elder가 위임장에 따라 2025년 8월 14일에 실행한 것으로 표시합니다.

Sheila G. Brockman, répertoriée avec une adresse à Atlanta, a déposé un Form 4 concernant SunLink Health Systems, Inc. (SSY) avec une date de transaction la plus ancienne du 14/08/2025. Le dossier identifie sa relation avec l'émetteur comme Dirigeante et indique qu'elle est ancienne vice-présidente de SSY et PDG d'une filiale. Le formulaire n'inclut aucun tableau de transactions rempli ni ne divulgue le type, la quantité ou le prix des titres négociés; le bloc de signature montre une exécution par M. Timothy Elder sous procuration le 14/08/2025.

Sheila G. Brockman, mit einer Adresse in Atlanta aufgeführt, hat ein Formular 4 in Bezug auf SunLink Health Systems, Inc. (SSY) eingereicht, mit dem frühesten Transaktionsdatum 14.08.2025. Die Einreichung kennzeichnet ihre Beziehung zum Emittenten als Beauftragte/r und vermerkt, dass sie frühere VP von SSY und CEO einer Tochtergesellschaft war. Das Formular enthält keine ausgefüllten Transaktionstabellen und gibt weder den Typ, die Menge noch den Preis der gehandelten Wertpapiere an; der Unterschriftsblock zeigt die Ausführung durch M. Timothy Elder unter Vollmacht am 14.08.2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Brockman Sheila G.

(Last) (First) (Middle)
900 CIRCLE 75 PARKWAY, SUITE 690

(Street)
ATLANTA GA 30339

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SUNLINK HEALTH SYSTEMS INC [ SSY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Former VP of SSY, & CEO of Sub
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
M. Timothy Elder, pursuant to a power of attorney 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for SSY?

The Form 4 was filed by Sheila G. Brockman, listed at an Atlanta address.

What is Sheila G. Brockman's relationship to SunLink Health Systems (SSY)?

The filing identifies her as an Officer and notes she is a former VP of SSY and CEO of a subsidiary.

When is the earliest transaction date reported on the Form 4?

The earliest transaction date shown on the form is 08/14/2025.

Does the Form 4 disclose the number or price of securities traded?

No. The transaction tables are not populated and the filing does not disclose type, quantity, or price of any securities.

Who signed the Form 4 and under what authority?

The form shows execution by M. Timothy Elder pursuant to a power of attorney on 08/14/2025.

Sunlink Hlth

NYSE:SSY

SSY Rankings

SSY Latest News

SSY Latest SEC Filings

SSY Stock Data

6.76M
5.04M
28.36%
14.64%
0.15%
Pharmaceutical Retailers
Services-general Medical & Surgical Hospitals, Nec
Link
United States
ATLANTA